TELA Bio (TELA) Capital Expenditures (2018 - 2026)
TELA Bio's (TELA) quarterly Capital Expenditures came in at $119000.0 in Q1 2026, up 271.88% year-on-year from $32000.0 in Q1 2025, and up 30.77% quarter-over-quarter from $91000.0 in Q4 2025.
TELA Bio (TELA) Capital Expenditures (2018 - 2026) Analysis & Trends
TELA Bio's Capital Expenditures history runs 9 years deep, the most recent figure standing at $119000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 271.88% year-over-year to $119000.0 in Q1 2026; TTM through Mar 2026 was $535000.0, a 36.69% decrease from a year earlier, with the FY2025 full-year figure at $448000.0, down 54.7% from the prior year.
- Capital Expenditures climbed to $119000.0 in Q1 2026 per TELA's latest filing, from $91000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $814000.0 in Q4 2024 and bottomed at -$819000.0 in Q4 2022.
- The 5-year median for Capital Expenditures is $115000.0 (2023), against an average of $98941.2.
- Biggest YoY gain for Capital Expenditures was 1427.27% in 2022; the steepest drop was 1286.96% in 2022.
- Year by year, Capital Expenditures stood at -$819000.0 in 2022, then jumped by 64.96% to -$287000.0 in 2023, then jumped by 383.62% to $814000.0 in 2024, then sank by 88.82% to $91000.0 in 2025, then jumped by 30.77% to $119000.0 in 2026.
- Per Business Quant, the three latest TELA Capital Expenditures figures stand at $119000.0 (Q1 2026), $91000.0 (Q4 2025), and $211000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | 119,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,000.00 |
| Mar 31, 2026 | 119,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 114,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 814,000.00 |
| Dec 31, 2024 | 814,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | -121,000.00 |
| Jun 30, 2024 | -121,000.00 |
| Mar 31, 2024 | 176,000.00 |
| Mar 31, 2024 | 176,000.00 |
| Dec 31, 2023 | -287,000.00 |
| Dec 31, 2023 | -287,000.00 |